Results 161 to 170 of about 5,260,738 (315)

The safe use of new technologies [PDF]

, 2010

core  

Training of Instrumentalists and Development of New Technologies on SOFIA

, 2009
This white paper is submitted to the Astronomy and Astrophysics 2010 Decadal Survey (Astro2010)1 Committee on the State of the Profession to emphasize the potential of the Stratospheric Observatory for Infrared Astronomy (SOFIA) to contribute to the ...
Allamandola, Louis J., Baluteau, Jean-Paul, Becklin, Eric E., Bjoraker, Gordon, Burton, Michael, Caroff, Lawrence J., Ceccarelli, Cecilia, Churchwell, Edward B., Clemens, Dan P., Cohen, Martin, Cruikshank, Dale P., Dinerstein, Harriet L., Dunham, Edward W., Erickson, Edwin F., Fazio, Giovanni G., Gatley, Ian, Gehrz, Robert D., Genzel, Reinhard, Graf, Paul, Greenhouse, Matthew A., Harper, Doyal A., Harvey, Paul M., Harwit, Martin, Hildebrand, Roger H., Hollenbach, David J., Lane, Adair P., Larson, Harold P., Lord, Steven D., Madden, Suzanne, Melnick, Gary J., Neufeld, David A., Olkin, Catherine B., Packham, Christopher C., Roellig, Thomas L., Roeser, Hans-Peter, Sandford, Scott A., Sellgren, Kristen, Simpson, Janet P., Storey, John W. V., Telesco, Charles M., Tielens, Alexander G. G. M., Tokunaga, Alan T., Townes, Charles H., Walker, Christopher K., Werner, Michael W., Whitcomb, Stanley E., Wolf, Juergen, Woodward, Charles E., Young, Erick T., Zmuidzinas, Jonas   +49 more
core   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Cereal and Cereal Products: Quality, Functionality, Health Security and Application of New Technologies. [PDF]

Foods
Šimurina O, Janić Hajnal E.
europepmc   +1 more source

New technologies in continuously reinforced concrete pavements [PDF]

, 2010
De Winne, Pieter, Rens, Luc
core   +1 more source

Older Workers and the Adoption of New Technologies [PDF]

For the first time data of German ICT and knowledge intensive service providers are used to analyze the relation between the age structure of the workforce and the probability of adopting new technologies.
Meyer, Jenny
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source

New technologies in medical education: An umbrella review on recent evidence. [PDF]

J Educ Health Promot
Mehraeen E, Khademzadeh S, Habibi P, Mirzapour P, Roozbahani MM, Haghi P, Mozafari N, SeyedAlinaghi S, Jahanfar S.   +8 more
europepmc   +1 more source

Circulating tumor cell viability during and after radiotherapy mirrors treatment response in cancer patients

Molecular Oncology, EarlyView.
Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy, Jana Löptien, Cornelia Coith, Afroditi Nanou, Katharina Hintelmann, Pinnschmidt Hans, Cordula Petersen, Klaus Pantel, Sabine Riethdorf, Kerstin Borgmann, Harriet Wikman   +10 more
wiley   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

Molecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel, Izabela Kubiak, Lena Rutkowska, Żaneta Kasprzyk, Łukasz Kępczyński, Michał Bednarek, Dariusz Sobieraj, Jacek Wilkosz, Piotr Kania, Adam Jędrzejczyk, Bogdan Kałużewski, Agnieszka Gach, Tadeusz Kałużewski   +12 more
wiley   +1 more source